Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06585852

Efficacy of Xenograft Alone or Mixed With Arginyl-Glycyl-Aspartic Acid (RGD) in Horizontal Ridge Augmentation With Split-crest Technique for Implant Placement

Efficacy of Xenograft Alone or Mixed With Arginyl-Glycyl-Aspartic Acid (RGD) in Horizontal Ridge Augmentation With Split-crest Technique for Implant Placement. A Randomized Clinical Trial

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
18 (estimated)
Sponsor
Al-Azhar University · Academic / Other
Sex
All
Age
18 Years – 30 Years
Healthy volunteers
Accepted

Summary

The aim of the present study is to evaluate the efficacy of xenograft alone or xenograft mixed with Arginylglycylaspartic acid (RGD) , in horizontal ridge augmentation with split-crest technique, for implant placement.

Detailed description

A comparative study for ridge augmentation procedure, With two groups. First group underwent a surgical ridge splitting procedure with ultrasonic bone surgery and grafting with Xenograft alone and implant placement. Second group underwent a surgical ridge splitting procedure with ultrasonic bone surgery Xenograft mix ed with Arginylglycylaspartic acid (RGD) and implant placement. Both groups were followed up for 1 and 3 months after loading.

Conditions

Interventions

TypeNameDescription
DRUGRGDStudy group main material
DRUGXenograftScaffold material of choice
PROCEDURESplit crest techniquePiezoelectric surgery

Timeline

Start date
2023-08-01
Primary completion
2024-09-01
Completion
2024-10-15
First posted
2024-09-19
Last updated
2024-09-19

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06585852. Inclusion in this directory is not an endorsement.

Efficacy of Xenograft Alone or Mixed With Arginyl-Glycyl-Aspartic Acid (RGD) in Horizontal Ridge Augmentation With Split (NCT06585852) · Clinical Trials Directory